ketoconazole has been researched along with bulleyaconitine a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Fu, Y; Li, N; Li, X; Liu, Z; Ni, J; Ou, X; Xu, Y; Yang, C; Zhang, R; Zhao, Z; Zhou, H; Zhu, L; Zuo, H | 1 |
1 other study(ies) available for ketoconazole and bulleyaconitine a
| Article | Year |
|---|---|
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions.
Topics: Aconitine; Animals; Cytochrome P-450 CYP3A; Drug Interactions; Ketoconazole; Membrane Proteins; Mice; Microsomes, Liver; Saccharomyces cerevisiae Proteins | 2022 |